KariéraCOVID-19
  1. Siemens Healthineers Slovakia
  2. Zobrazovacia diagnostika
  3. Molecular Imaging
  4. Nuclear Medicine News & Stories

Nuclear Medicine News & Stories

By Takeshi Shimizu, PhD

Image-based selection of Alzheimer’s disease therapy
 2022-11-30
PET imaging and emerging immunotherapy candidates are beginning to enable image-based therapy personalization for dementia.
Healthcare Trends

By Catherine Marcic Joyce

EANM’s 35th congress reunites nuclear medicine industry
 2022-11-29
Barcelona, Spain, welcomed attendees from around the globe as they assembled in person for the European Association of Nuclear Medicine’s 35th Annual Congress.
News

By Claudette Lew

Whole-body parametric imaging expands clinical opportunities

 2022-10-05
A team at Aarhus University Hospital in Denmark validates the clinical potential value of routine whole-body parametric imaging with PET/CT.

By Florian Bayer

Advances in PSMA-based approach for prostate cancer
 2022-09-13
Nuclear medicine, urology, and biomedical engineering experts discuss a new PSMA-based approach that combines diagnosis and therapeutics for the treatment of prostate cancer.
Healthcare Trends
Claudette Lew
SNMMI 2022 annual meeting showcases the future of nuclear medicine
 2022-09-12
Siemens Healthineers hosts booth and a luncheon symposium and launches new product at SNMMI 2022.
News

By Sameh Fahmy

A champion of PET innovation
 2022-08-19

An early PET advocate recounts the origins of PET implementation at RPA Hospital in Australia and today uses Biograph Vision Quadra.

Customer Experience

By Claudette Lew

Fortifying the foundation for personalized medicine
 2022-07-11
PETNET Solutions invests in its network to increase patient access to PET biomarkers and support future biomarker development.
Personalized Medicine

By Linda Brookes

Fully integrated SPECT/CT modernizes facilities to maximize abilities

 2022-06-09
Nuclear medicine experts on two continents describe how the new fully integrated SPECT/CT serves more patients and signals the beginning of a new era in nuclear imaging.
Customer Experience
By Santina Russo

Soaring to new heights with SPECT/CT
 2022-04-08
Since its introduction more than two decades ago, SPECT/CT imaging has seen significant technological advances that are expanding the modality’s power and accuracy. SPECT/CT expert Klaus Strobel from Lucerne Cantonal Hospital in Switzerland reveals how the method improves individual patient care and where he sees future clinical applications.
Customer Experience
Meeting of the minds
 2022-04-07
Biograph Vision Quadra Meet and Greet welcomed nuclear medicine experts from five countries to share their insights and learn from one another.
Customer Experience
By Sameh Fahmy

How we developed Auto ID
 2021-12-01
Selecting a single checkbox alongside the words “Enable Auto ID” brings the power of artificial intelligence into routine clinical use in molecular imaging: an action that saves precious time and streamlines processes that would otherwise be tedious.
Customer Experience
By Catherine Marcic Joyce

EANM Congress 2021 captivates global nuclear medicine industry
 2021-11-30

The 34th Annual EANM Congress provided the ideal opportunity for the nuclear medicine community to highlight new technologies, explore innovations in patient care, and participate in conversations with thought leaders.

News
Marco Viscione ; Axel Rominger, MD, PhD ; and Kuangyu Shi, PhD stand in front of their department’s whole-body molecular imaging PET/CT system : Biograph Vision Quadra.

By Sameh Fahmy

A quantum leap in PET/CT imaging

 2021-05-28

For nuclear medicine clinicians and researchers at Switzerland’s Inselspital, Bern University Hospital, being the first site to install Biograph Vision Quadra™ marked the conclusion of a process that began when their team crossed the Atlantic to consult with Siemens Healthineers as they designed the next-generation whole-body PET/CT scanner.

Customer Experience

By Linda Brookes 

A step toward precision treatment in breast cancer
 2021-04-15
Staff at the first imaging center in the United States to receive and utilize doses of the new radiopharmaceutical, Cerianna™ (fluoroestradiol F 18) injection, describe how it could impact their practice and the subsequent treatment of patients with recurrent or metastatic breast cancer.
Customer Experience

By Takeshi Shimizu, PhD

An examination of nuclear neurology in Japan
 2021-03-22
Population aging has transformed many aspects of society. Senior citizens are increasingly acknowledged as important contributors and infrastructure development facilitates their continued engagement. By the same token, senior citizens’ improved level of activity, productivity, and socioeconomic status impact society and healthcare in unexpected ways.
Healthcare Trends